TODMORDEN GROUP PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: B84006 | TODMORDEN, OL14 5RN
Showing results 101-150 of 702
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Hydrocortisone | 785 | 21.9K | £4.1K | +75.1% ▲ |
| Lactulose | 762 | 490.4K | £4.6K | +131.5% ▲ |
| Insulin aspart | 759 | 5,142 | £32.8K | +99.3% ▲ |
| Felodipine | 758 | 28.8K | £4.6K | +27.6% ▲ |
| Gliclazide | 737 | 33.2K | £1.3K | -13.4% ▼ |
| Other emollient preparations | 736 | 406.8K | £5.6K | +22.5% ▲ |
| Solifenacin | 734 | 25.5K | £1.3K | +53.8% ▲ |
| Estriol | 724 | 19.1K | £12.6K | +240.2% ▲ |
| Famotidine | 707 | 21.1K | £11.6K | +44.9% ▲ |
| Spironolactone | 699 | 23.9K | £6.6K | +29.6% ▲ |
| Diclofenac diethyl | 695 | 80.5K | £4.3K | +95.7% ▲ |
| Semaglutide | 686 | 10.8K | £54.6K | +184.9% ▲ |
| Betahistine hydrochloride | 658 | 49.7K | £1.9K | +175.6% ▲ |
| Ropinirole hydrochloride | 655 | 8,511 | £4.6K | +516.5% ▲ |
| Sumatriptan succinate | 623 | 6,290 | £3.8K | +75.9% ▲ |
| Sacubitril/valsartan | 621 | 27.6K | £45.2K | +159.3% ▲ |
| Bumetanide | 613 | 25.1K | £2.5K | +125.0% ▲ |
| Risperidone | 613 | 22.6K | £3.7K | +142.3% ▲ |
| Donepezil hydrochloride | 604 | 10.2K | £1.6K | +95.7% ▲ |
| Sitagliptin | 604 | 18.5K | £1.3K | +54.9% ▲ |
| Edoxaban | 581 | 15.0K | £25.0K | -17.1% ▼ |
| Carbamazepine | 579 | 57.9K | £3.6K | +95.1% ▲ |
| Nifedipine | 571 | 28.9K | £4.9K | +204.7% ▲ |
| Aripiprazole | 565 | 17.7K | £4.0K | +122.0% ▲ |
| Mirabegron | 563 | 13.5K | £12.5K | +40.2% ▲ |
| Glyceryl trinitrate | 553 | 958 | £1.3K | +133.8% ▲ |
| Betamethasone valerate | 551 | 45.8K | £4.1K | +43.1% ▲ |
| Mebeverine hydrochloride | 549 | 45.6K | £5.5K | +76.8% ▲ |
| Prochlorperazine maleate | 547 | 26.7K | £1.6K | +170.6% ▲ |
| Diltiazem hydrochloride | 545 | 23.8K | £4.5K | +77.5% ▲ |
| Estradiol | 544 | 14.8K | £6.9K | +101.6% ▲ |
| Melatonin | 543 | 35.0K | £14.2K | +63.3% ▲ |
| Desogestrel | 542 | 105.3K | £3.4K | +36.7% ▲ |
| Budesonide | 537 | 694 | £16.9K | -0.9% vs avg |
| 536 | 3,598 | £1.7K | +114.8% ▲ | |
| Eplerenone | 532 | 12.4K | £1.5K | +100.6% ▲ |
| Latanoprost | 527 | 7,928 | £2.7K | +8.6% ▲ |
| Hyoscine butylbromide | 515 | 40.1K | £3.0K | +121.0% ▲ |
| Sodium valproate | 511 | 58.1K | £8.1K | +60.7% ▲ |
| Quinine sulfate | 498 | 12.1K | £1.8K | +72.0% ▲ |
| Methotrexate | 496 | 14.6K | £867 | +52.4% ▲ |
| Tirzepatide | 495 | 526 | £48.5K | +154.9% ▲ |
| Loperamide hydrochloride | 464 | 36.3K | £1.8K | +99.2% ▲ |
| Timolol and bimatoprost | 462 | 4,431 | £7.1K | +204.4% ▲ |
| Tiotropium bromide | 461 | 3,709 | £11.2K | +51.6% ▲ |
| Glimepiride | 452 | 15.0K | £461 | +389.9% ▲ |
| Fluticasone furoate/vilanterol | 449 | 502 | £11.7K | +190.0% ▲ |
| Mesalazine (Systemic) | 441 | 68.2K | £24.0K | +84.1% ▲ |
| Alogliptin | 440 | 14.6K | £13.2K | +73.5% ▲ |
| Beclometasone dipropionate | 439 | 452 | £1.3K | +104.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.